Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Hans-Heinrich Reckeweg Clinical Case Award 2017 - Submission closedBiologische Heilmittel Heel GmbH supports the acknowledgement of clinical case reporting in the form of the annual Hans-Heinrich Reckeweg Clinical Case Award. The Award is bestowed on the premises of the International Award Committee for excellent reporting in accordance with the CARE guidelines (care-statement.org), ensuring transparency and accuracy of health research reporting. The submission is now closed. More on the Hans-Heinrich Reckeweg Clinical Case Award
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases